发明名称 |
LEVONORGESTREL-ONLY-COMPOSITION FOR OPTIMIZED ORAL CONTRACEPTION WITH DEFINED LEVONORGESTREL CONTENT, DOSAGE REGIMEN AND PHARMACEUTICAL PREPARATION |
摘要 |
Based on specific experimental studies the invention relates to an optimized levonorgestrel-only-composition for improved continuous oral contraception with consequences for suitable pharmaceutical preparations for the same purpose and with defined levonorgestrel content . The invention relates to a pharmaceutical composition for oral contraception for a woman of fertile age consisting of 60 to 100 µg of levonorgestrel and one or more pharmaceutical acceptable carriers and excipients. Furthermore, the invention relates to a pharmaceutical preparation for oral contraception consisting of a number of separately packed and individually removable daily dosage units intended for consecutive daily oral administration, each dosage unit consisting of 60 to 100 µg of levonorgestrel and one or more pharmaceutical acceptable carriers and excipients. Additionally, the invention relates to a dosage regimen, i.e. to the use of an oral dosage form consisting of 60 to 100 µg of levonorgestrel and one or more pharmaceutical acceptable carriers and excipients per dosage unit for oral contraception for a woman of fertile age by administering one dosage unit daily during the complete menstruation cycle. |
申请公布号 |
EP2916845(A1) |
申请公布日期 |
2015.09.16 |
申请号 |
EP20130786654 |
申请日期 |
2013.11.04 |
申请人 |
NAARI AG |
发明人 |
OETTEL, MICHAEL;KOCHHAR, PRITHI S.;OSTERWALD, HERMANN |
分类号 |
A61K31/565;A61P15/18 |
主分类号 |
A61K31/565 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|